Skip Navigation

Phase I of the PRG Process

On this page:



The PRG Process at-a-glance

Phase I: Recommendationarrow pointing to phase 2Phase II: Implementationarrow pointing to phase 3Phase III: Reporting
  • Hold leadership meeting
  • Conduct concept mapping
  • Hold planning meeting
  • Hold roundtable
  • Develop report
  • Present key findings to HHS agency representatives
  • Establish working groups
  • Map initiatives and projects to PRG recommendations
  • Prepare response to PRG
  • Hold response meeting
  • Prepare and promote implementation plan
  • Select measures of progress
  • Collect progress data
  • Develop progress report
  • Discuss progress with PRG
  • Prepare and promote revised implementation plan

Phase I: Recommendation

Progress Review Groups (PRGs) are panels composed of prominent scientific, medical, public health, and advocacy community members who are selected to assess the state of the science and practice and to recommend future priorities for a specific area of concern - in this case cancer health disparities. The CHD PRG will charge representatives from agencies across HHS, as well as external experts, with identifying and prioritizing research and practice needs for addressing cancer-related health disparities. This includes:

top of page

The Background Paper

The Background Paper will serve as a reference throughout the Progress Review process. It will also identify the key cancer health disparity issues that have been documented in peer-reviewed publications and, to the extent possible, their nature, magnitude, and underlying correlates. This analysis will examine broad questions:

Concept Mapping

A concept mapping exercise involving over 100 people, most of whom will later participate in the Roundtable Meeting, will be used to identify key concepts that participants would like to address during the progress review. The statements generated by concept mapping participants will be sorted into conceptual categories and rated according to importance and feasibility. This information will help participants identify the most useful approaches within and across HHS to reduce cancer health disparities. The key concepts identified will also be used to help organize the content of the breakout discussion groups during the upcoming Roundtable Meeting.

Key Roles and Responsibilities in the PRG Process

The Executive Director, who is a scientist and/or clinician and expert in the field of cancer health disparities, is chosen to plan and guide Phase I of the PRG process.

PRG Co-chairs are selected by the HHS leadership based on their contributions to the field and their leadership and organizational skills.

PRG members are selected to represent their area of expertise on the panel.

The Roundtable provides an opportunity for researchers, health care professionals, policymakers, and advocates to work together to develop an integrated set of recommendations for prioritizing HHS research, development, dissemination, and delivery activities in cancer health disparities.

At the conclusion of Phase I, the CHD PRG will submit to HHS a comprehensive report for department-wide consideration a set of recommended actions and guidelines to systematically connect scientific discovery, intervention development, and delivery of interventions and policy changes across HHS agencies. This document will include a consensus of what is already known concerning cancer health disparities as well as advancing scientific research, developing interventions based upon that research and furthermore, delivering these interventions to those in need.

Discoveryhorizontal line with arrowheads on each endDevelopmenthorizontal line with arrowheads on each endDelivery
  • Understand the biologic, socio-cultural, economic & healthcare system pathways that influence cancer-related health disparities
  • Evaluate & identify genetic & environmental risk factors
  • Improve & expand measures of socioeconomic status
  • Increase community-based participatory research
  • Facilitate interagency & public-private partnerships
  • Expand dissemination & diffusion research for underserved populations
  • Include more minorities & women in clinical trials
  • Develop bioinformatics/tissue banks/registries
  • Expand geographic & population surveillance
  • Implement evidence-based prevention strategies at the health care system & community levels
  • Expand early detection among high-risk groups
  • Ensure access to standard care for all cancer patients
  • Improve access to state-of-the-art care for underserved patients
  • Inform policy making decisions related to cancer care

top of page